Abstract 2406: A novel covalent BRD4 degrader-HER2-targeting antibody-drug conjugate (DAC) overcomes trastuzumab deruxtecan resistance in HER2-positive cancers.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Xin Yu, Bin Yang, Wendi Ni, Haibo Liu, Jan Willem Theunissen, Jesse Chen, Jin Wang
Institution: Baylor College of Medicine
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148756261
Cites:
Cited by:
Related to: